1. Home
  2. GNT vs HBIO Comparison

GNT vs HBIO Comparison

Compare GNT & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNT
  • HBIO
  • Stock Information
  • Founded
  • GNT 2011
  • HBIO 1901
  • Country
  • GNT United States
  • HBIO United States
  • Employees
  • GNT N/A
  • HBIO N/A
  • Industry
  • GNT Finance/Investors Services
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • GNT Finance
  • HBIO Industrials
  • Exchange
  • GNT Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • GNT 93.3M
  • HBIO 93.8M
  • IPO Year
  • GNT N/A
  • HBIO 2000
  • Fundamental
  • Price
  • GNT $5.78
  • HBIO $1.93
  • Analyst Decision
  • GNT
  • HBIO
  • Analyst Count
  • GNT 0
  • HBIO 0
  • Target Price
  • GNT N/A
  • HBIO N/A
  • AVG Volume (30 Days)
  • GNT 40.9K
  • HBIO 248.4K
  • Earning Date
  • GNT 01-01-0001
  • HBIO 03-06-2025
  • Dividend Yield
  • GNT 6.61%
  • HBIO N/A
  • EPS Growth
  • GNT N/A
  • HBIO N/A
  • EPS
  • GNT 0.95
  • HBIO N/A
  • Revenue
  • GNT N/A
  • HBIO $97,732,000.00
  • Revenue This Year
  • GNT N/A
  • HBIO N/A
  • Revenue Next Year
  • GNT N/A
  • HBIO $4.32
  • P/E Ratio
  • GNT $5.36
  • HBIO N/A
  • Revenue Growth
  • GNT N/A
  • HBIO N/A
  • 52 Week Low
  • GNT $4.59
  • HBIO $1.81
  • 52 Week High
  • GNT $5.40
  • HBIO $4.93
  • Technical
  • Relative Strength Index (RSI)
  • GNT 63.52
  • HBIO 40.61
  • Support Level
  • GNT $5.19
  • HBIO $1.81
  • Resistance Level
  • GNT $5.75
  • HBIO $2.07
  • Average True Range (ATR)
  • GNT 0.09
  • HBIO 0.13
  • MACD
  • GNT 0.05
  • HBIO -0.01
  • Stochastic Oscillator
  • GNT 100.00
  • HBIO 25.53

About GNT GAMCO Natural Resources Gold & Income Trust

GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Share on Social Networks: